Taking PrandiMet and Breastfeeding -- Is It Safe?
At least one of the components in
PrandiMet™ (
repaglinide and metformin) does pass through breast milk in humans. If you are breastfeeding a child, you should talk with your healthcare provider about taking PrandiMet.
What Does the Research Say?
Metformin (one of the components of PrandiMet) passes through breast milk in humans in relatively low amounts. In general, studies suggest that this does not pose a risk to the breastfed child. Metformin is usually considered compatible with breastfeeding.
Studies show that
repaglinide (the other component of PrandiMet) passes through breast milk in rats. The chemical structure of repaglinide suggests that it probably will pass through breast milk in humans, although this has not yet been studied. When given to breastfeeding rats, repaglinide lowered the blood sugar in the breastfed pups and also seemed to increase the risk of skeletal deformities, although it is unknown if similar problems could occur in humans. In general, repaglinide is not considered compatible with breastfeeding, due to the risk of skeletal problems and low blood sugar levels in the infant.
Talking With Your Healthcare Provider About PrandiMet and Breastfeeding
You should talk with your healthcare provider about PrandiMet and breastfeeding.
Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about PrandiMet and breastfeeding in your particular situation.
HealthSavvy Sign In
|
